Login Register Cart 0
Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Advanced Oral Drug Delivery Systems for Combating and Preventing Paediatric Periodontal Disease

Author(s): Amanda Frank, Preet Amol Singh, Komal Singh, Saahil Arora, Rajiv Sharma and Neha Bajwa*

Volume 21, Issue 12, 2024

Published on: 23 August, 2023

Page: [2261 - 2270] Pages: 10

DOI: 10.2174/1570180820666230823093604

Price: $65

conference banner
Abstract

The oral route is the most common route of administration of drugs. Over 90% of all the available marketed pharmaceutical products are oral formulations. Oral drugs are used in different courses of treatment including the prevention of tooth decay. Tooth decay is the permanent damage of the enamel which leads to the formation of cavities. It can be prevented with good oral hygiene and enough fluorides in the body. Fluorides can be administered both topically (toothpastes) and systemically (supplements). Fluoride supplements fall under oral drug delivery systems. They come in the form of tablets, lozenges, and liquids. However, challenges are faced when it comes to oral drug delivery in children. The development of paediatric drugs is a difficult undertaking since many pharmaceutically active compounds have low water solubility, instability, or an unpleasant taste. Children are unable to tolerate bitter or unpleasant- tasting formulations, as well as huge pills and capsules. Due to various biological, biochemical, and physical barriers faced by oral drug delivery systems, new approaches have been developed to address these challenges such as the application of nanotechnology in drug development. Jellies for oral administration on the other hand are a new approach for the delivery of drugs with bitter tastes as well as for age groups such as children and elders. They are clear, translucent, or non-greasy semisolid products that can be used both externally and internally. In-depth, aspects of these factors will be discussed in this review paper including oral dosage forms for paediatrics, tooth decay and its pathogenesis, preventive measures and setbacks of each measure as well as the future perspectives.

Keywords: Tooth decay, systemic fluorides, topical fluorides, paediatric oral drug delivery, jellies, fluoride formulations.

« Previous Next »
[1]
Alqahtani, M.S.; Kazi, M.; Alsenaidy, M.A.; Ahmad, M.Z. Advances in oral drug delivery. Front. Pharmacol., 2021, 12, 618411.
[2]
Murugesan, S.; Gowramma, B.; Lakshmanan, K.; Reddy Karri, V.V.S.; Radhakrishnan, A. Oral modified drug release solid dosage form with special reference to design; An overview. Curr. Drug Res. Rev., 2020, 12(1), 16-25.
[http://dx.doi.org/10.2174/2589977511666191121094520] [PMID: 31755398]
[3]
Sahoo, D.; Bandaru, R.; Samal, S.K.; Naik, R.; Kumar, P.; Kesharwani, P. Oral drug delivery of nanomedicine. In: Theory and Applications of Nonparenteral Nanomedicines; Elsevier, 2021; pp. 181-207.
[http://dx.doi.org/10.1016/B978-0-12-820466-5.00009-0]
[4]
Bhutani, U.; Basu, T.; Majumdar, S. Oral drug delivery: Conventional to long acting new-age designs. Eur. J. Pharm. Biopharm., 2021, 162, 23-42.
[http://dx.doi.org/10.1016/j.ejpb.2021.02.008] [PMID: 33631319]
[5]
Scholz, O.A.; Wolff, A.; Schumacher, A.; Giannola, L.I.; Campisi, G.; Ciach, T.; Velten, T. Drug delivery from the oral cavity: Focus on a novel mechatronic delivery device. Drug Discov. Today, 2008, 13(5-6), 247-253.
[http://dx.doi.org/10.1016/j.drudis.2007.10.018] [PMID: 18342801]
[6]
Rubbens, J.; Mols, R.; Brouwers, J.; Augustijns, P. Exploring gastric drug absorption in fasted and fed state rats. Int. J. Pharm., 2018, 548(1), 636-641.
[http://dx.doi.org/10.1016/j.ijpharm.2018.07.017] [PMID: 29981414]
[7]
Erica, M.; Timothy, S.L.; Howard, S.S. Medication related nausea and vomiting in palliative medicine. Ann. Palliat. Med., 2012, 1(2), 161-176.
[8]
Gupta, H.; Bhandari, D.; Sharma, A. Recent trends in oral drug delivery: A review. Recent Pat. Drug Deliv. Formul., 2009, 3(2), 162-173.
[http://dx.doi.org/10.2174/187221109788452267] [PMID: 19519576]
[9]
Tubert-Jeannin, S.; Auclair, C.; Amsallem, E.; Tramini, P.; Gerbaud, L. Ruffieux, C Fluoride supplements (tablets, drops, lozenges or chewing gums) for preventing dental caries in children. Cochrane Database Syst. Rev., 2019, 2011(12), CD007592.
[10]
Guzmán-Armstrong, S. Rampant Caries. J. Sch. Nurs., 2005, 21(5), 272-278.
[http://dx.doi.org/10.1177/10598405050210050501] [PMID: 16262438]
[11]
Wright, J.T. The burden and management of dental caries in older children. Pediatr. Clin. North Am., 2018, 65(5), 955-963.
[http://dx.doi.org/10.1016/j.pcl.2018.05.005]
[12]
Delimont, N.M.; Carlson, B.N. Prevention of dental caries by grape seed extract supplementation: A systematic review. Nutr. Health, 2020, 26(1), 43-52.
[http://dx.doi.org/10.1177/0260106019887890]
[13]
Frazão, P. The use of fluorides in public health: 65 years of history and challenges from brazil. Int. J. Environ. Res. Public Health, 2022, 19(15), 9741.
[http://dx.doi.org/10.3390/ijerph19159741] [PMID: 35955101]
[14]
Violeta, C.; Milagros, J.T.; Augusto, R. E-B.; Angeliz, E-B. Effectiveness of silver diamine fluoride in caries prevention and arrest: A systematic literature review. Gen. Dent., 2017, 65(3), 22-29.
[15]
Chi, D.L.; Scott, J.A.M. Added sugar and dental caries in children: A scientific update and future steps. Dent. Clin. North Am., 2019, 63(1), 17-33.
[http://dx.doi.org/10.1016/j.cden.2018.08.003]
[16]
Okunseri, C.; Gonzalez, C.; Hodgson, B. Children’s oral health assessment, prevention, and treatment. Pediatr. Clin. North Am., 2015, 62(5), 1215-1226.
[17]
Takahashi, N.; Nyvad, B. The role of bacteria in the caries process: Ecological perspectives. J. Dent. Res., 2011, 90(3), 294-303.
[http://dx.doi.org/10.1177/0022034510379602] [PMID: 20924061]
[18]
Ramos-Jorge, J.; Alencar, B.M.; Pordeus, I.A.; Soares, M.E.C.; Marques, L.S.; Ramos-Jorge, M.L.; Paiva, S.M. Impact of dental caries on quality of life among preschool children: Emphasis on the type of tooth and stages of progression. Eur. J. Oral Sci., 2015, 123(2), 88-95.
[http://dx.doi.org/10.1111/eos.12166] [PMID: 25557987]
[19]
Selwitz, R.H. Dental caries. Lancet J., 2007, 369(9555), 51-59.
[20]
Anne Aamdal, S.; Fernanda Cristina, P. The biofilm concept: Consequences for future prophylaxis of oral diseases? Crit. Rev. Oral Biol. Med., 2004, 15(1), 4-12.
[21]
Featherstone 1, J.D.B. The continuum of dental caries- evidence for a dynamic disease process. J. Dent. Res., 2004, 83(Spec No C), C39-42.
[22]
Nyvad, B.; Takahashi, N. Integrated hypothesis of dental caries and periodontal diseases. J. Oral Microbiol., 2020, 12(1), 1710953.
[http://dx.doi.org/10.1080/20002297.2019.1710953]
[23]
Taipale, T.; Pienihäkkinen, K.; Alanen, P.; Jokela, J.; Söderling, E. Administration of Bifidobacterium animalis lactis BB-12 in early childhood: A post-trial effect on caries occurrence at four years of age. Caries Res., 2013, 47(5), 364-372.
[http://dx.doi.org/10.1159/000348424] [PMID: 23571819]
[24]
Aaltonen, A.S.; Suhonen, J.T.; Tenovuo, J. Efficacy of a slow-release device containing fluoride, xylitol and sorbitol in preventing infant caries. Acta Odontol. Scand., 2000, 58(6), 285-292.
[25]
Xu, J.; Shi, H.; Luo, J.; Yao, H.; Wang, P.; Li, Z. Advanced materials for enamel remineralization. Front. Bioeng. Biotechnol., 2022, 10, 985881.
[26]
In: Monogr Oral Sci; Twetman, S.; Fontana, M. Detection, assessment, diagnosis and monitoring of caries. In: Monographs in Oral Science; Karger: Basel, 2009, p. 21.
[27]
Toumba, K.J. Slow-release devices for fluoride delivery to high-risk individuals. Caries Res., 2001, 35(S1), 10-13.
[28]
Kagihara, L.E.; Niederhauser, V.P.; Stark, M. Assessment, management, and prevention of early childhood caries. J. Am. Acad. Nurse Pract., 2009, 21(1), 1-10.
[http://dx.doi.org/10.1111/j.1745-7599.2008.00367.x] [PMID: 19125889]
[29]
Dental Health of Children. Available from: http://www.health.gov/healthypeople/document/pdf/Volume2/21
[30]
Duangthip, D.; Chen, K.J.; Gao, S.S.; Lo, E.C.M.; Chu, C.H. Managing early childhood caries with atraumatic restorative treatment and topical silver and fluoride agents. Int. J. Environ. Res. Public Health, 2017, 14(10), 1204.
[31]
Applied Sciences., Munteanu, A.; Holban, A.M.; Păuna, M.R.; Imre, M.; Farcașiu, A.T.; Farcașiu, C. Review of professionally applied fluorides for preventing dental caries in children and adolescents. Appl. Sci., 2022, 12(3), 1054.
[32]
Mathur, V.P. Dhillon, JK Dental caries: A disease which needs attention. Indian J. Pediatr., 2018, 85(3), 202-206.
[http://dx.doi.org/10.1007/s12098-017-2381-6]
[33]
Sebastian, S.T.; Siddanna, S. Total and free fluoride concentration in various brands of toothpaste marketed in india. J. Clin. Diagn. Res., 2015, 9(10), ZC09-ZC12.
[http://dx.doi.org/10.7860/JCDR/2015/13382.6578] [PMID: 26557607]
[34]
Marília Afonso, R.B.; Juliano Pelim, P.; Heitor Marques, H.; Jacob Martien, T.C. Mechanisms of action of fluoride for caries control. Monogr. Oral Sci., 2011, 22, 97-114.
[35]
Horst, J.A.; Tanzer, J.M.; Milgrom, P.M. Fluorides and other preventive strategies for tooth decay. Dent. Clin. North Am., 2018, 62(2), 207-234.
[http://dx.doi.org/10.1016/j.cden.2017.11.003]
[36]
Hellwig, E.; Lennon, A. Systemic versus topical fluoride. Caries Res., 2004, 38(3), 258-262.
[37]
Carey, C.M. Focus on fluorides: Update on the use of fluoride for the prevention of dental caries. J. Evid. Based Dent. Pract., 2014, 14, 95-102.
[http://dx.doi.org/10.1016/j.jebdp.2014.02.004] [PMID: 24929594]
[38]
Zohoori, F.V.; Maguire, A. Are there good reasons for fluoride labelling of food and drink? Br. Dent. J., 2018, 224(4), 215-217.
[39]
Chávez, B.A.; Vergel, G.B.; Cáceres, C.P.; Perazzo, M.F.; Vieira-Andrade, R.G.; Cury, J.A. Fluoride content in children’s dentifrices marketed in Lima, Peru. Braz. Oral Res., 2019, 33, e051.
[http://dx.doi.org/10.1590/1807-3107bor-2019.vol33.0051] [PMID: 31269115]
[40]
Clark, M.B.; Keels, M.A.; Slayton, R.L.; Braun, P.A.; Fisher-Owens, S.A.; Huff, Q.A.; Karp, J.M.; Tate, A.R.; Unkel, J.H.; Krol, D. Fluoride use in caries prevention in the primary care setting. Pediatrics, 2020, 146(6), e2020034637.
[http://dx.doi.org/10.1542/peds.2020-034637] [PMID: 33257404]
[41]
Ullah, R. Sohail Zafar, B Oral and dental delivery of fluoride: A review. Fluoride, 2015, 48(3)
[42]
Aoun, A.; Darwiche, F.; al Hayek, S.; Doumit, J. The fluoride debate: The pros and cons of fluoridation. Prev. Nutr. Food Sci., 2018, 23(3), 171-180.
[43]
Pollick, H. The role of fluoride in the prevention of tooth decay. Pediatr. Clin. North Am., 2018, 65(5), 923-940.
[http://dx.doi.org/10.1016/j.pcl.2018.05.014]
[44]
Milgrom, P.; Zero, D.T.; Tanzer, J.M. An examination of the advances in science and technology of prevention of tooth decay in young children since the Surgeon General’s Report on Oral Health. Acad. Pediatr., 2009, 9(6), 404-409.
[http://dx.doi.org/10.1016/j.acap.2009.09.001] [PMID: 19837019]
[45]
Wong, H.M. Childhood caries management. Int. J. Environ. Res. Public Health, 2022, 19(14), 8527.
[46]
Robert, J. W.; Sharon L, T.; Krishna, A.; Julie, F-H.; Daniel, M.M. Topical fluoride for caries prevention: Executive summary of the updated clinical recommendations and supporting systematic review. J. Am. Dent. Assoc., 2013, 144(11), 1279-1291.
[47]
Best practices:Fluoride therapy 302 the reference manual of pediatric dentistry purpose. Available from: www.sign.ac.uk/assets/sign138. pdf
[48]
Bubnowicz, L.; França, R. Calcium and fluoride interaction in human enamel at nanoscale: An XPS assessment. Appl. Sur. Sci. Adv., 2022, 11, 100306.
[http://dx.doi.org/10.1016/j.apsadv.2022.100306]
[49]
Mullen, J. History of water fluoridation. Br. Dent. J., 205, 199(S7), 1-4.
[50]
Correia, C.; Steven Marc, L.F. Impact of fluoride in the prevention of caries and erosion. In: Fluoride and the Oral Systemic Fluoride; Karger: Basel, 2011.
[51]
Toumba, K.J.; Twetman, S.; Splieth, C.; Parnell, C.; van Loveren, C.; Lygidakis, N. Guidelines on the use of fluoride for caries prevention in children: An updated EAPD policy document. Eur. Arch. Paediatr. Dent., 2019, 20(6), 507-516.
[52]
Toumba, K.J.; Curzon, M.E.J. A clinical trial of a slow-releasing fluoride device in children. Caries Res., 2005, 39(3), 195-200.
[http://dx.doi.org/10.1159/000084798] [PMID: 15914981]
[53]
Stephen, K.W. Systemic fluorides: Drops and tablets. Caries Res., 1993, 27(S1), 9-15.
[54]
Malkawi, W.A.; Alrafayah, E.; Alhazabreh, M.; Abulaila, S.; Al-Ghananeem, A.M. Formulation challenges and strategies to develop pediatric dosage forms. Children, 2022, 9(4), 488.
[55]
Lopez, F.L.; Ernest, T.B.; Tuleu, C.; Gul, M.O. Formulation approaches to pediatric oral drug delivery: Benefits and limitations of current platforms. Expert Opin. Drug Deliv., 2015, 12(11), 1727-1740.
[56]
Ranmal, S.R.; Cram, A.; Tuleu, C. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children’s Acceptability of Oral Formulations (CALF) Study. Int. J. Pharm., 2016, 514(1), 296-307.
[http://dx.doi.org/10.1016/j.ijpharm.2016.07.054] [PMID: 27863675]
[57]
Maniruzzaman, M.; Boateng, J.S.; Chowdhry, B.Z.; Snowden, M.J.; Douroumis, D. A review on the taste masking of bitter APIs: Hot-melt extrusion (HME) evaluation. Drug Dev. Ind. Pharm., 2014, 40(2), 145-156.
[58]
Kole, S.S.; Kuchekar, A.B.; Limaye, D.A. Advancements in formulation approaches to pediatric oral drug delivery systems. Hacettepe Uni. J. Faculty Pharma., 2021, 41(4), 254-265.
[http://dx.doi.org/10.52794/hujpharm.941321]
[59]
van Riet - Nales, D.A.; Römkens, E.G.A.W.; Saint-Raymond, A.; Kozarewicz, P.; Schobben, A.F.A.M.; Egberts, T.C.G.; Rademaker, C.M.A. Oral medicines for children in the European paediatric investigation plans. PLoS One, 2014, 9(6), e98348.
[http://dx.doi.org/10.1371/journal.pone.0098348] [PMID: 24897509]
[60]
Strickley, R.G.; Iwata, Q.; Wu, S. Dahl, TC Pediatric drugs - Review of commercially available oral formulations. J. Pharm. Sci., 2008, 97(5), 1731-1774.
[61]
Sunil, S.; Kumar Sharma, U.; Arathy, S. Pharmaceutical Jellies: A novel way of drug delivery. J. Pharm. Sci. Res., 2020, 12(7), 904-909.
[62]
Preis, M. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use. AAPS PharmSciTech, 2015, 16(2), 234-241.
[63]
Lajoinie, A.; Henin, E.; Kassai, B.; Terry, D. Solid oral forms availability in children: A cost saving investigation. Br. J. Clin. Pharmacol., 2014, 78(5), 1080-1089.
[http://dx.doi.org/10.1111/bcp.12442] [PMID: 24965935]
[64]
Cilurzo, F.; Musazzi, U.M.; Franzé, S.; Selmin, F.; Minghetti, P. Orodispersible dosage forms: Biopharmaceutical improvements and regulatory requirements. Drug Discov. Today, 2018, 23(2), 251-259.
[65]
Badgujar, B.; Mundada, A. The technologies used for developing orally disintegrating tablets: A review. Acta Pharm., 2011, 61(2), 117-139.
[http://dx.doi.org/10.2478/v10007-011-0020-8] [PMID: 21684842]
[66]
Mistry, P.; Batchelor, H. Evidence of acceptability of oral paediatric medicines: A review. J. Pharm. Pharmacol., 2017, 69(4), 361-376.
[http://dx.doi.org/10.1111/jphp.12610]
[67]
Brniak, W.; Maślak, E.; Jachowicz, R. Orodispersible films and tablets with prednisolone microparticles. Eur. J. Pharm. Sci., 2015, 75, 81-90.
[http://dx.doi.org/10.1016/j.ejps.2015.04.006] [PMID: 25889975]
[68]
Goel, H.; Rai, P.; Rana, V.; Tiwary, A. Orally disintegrating systems: Innovations in formulation and technology. Recent Pat. Drug Deliv. Formul., 2008, 2(3), 258-274.
[http://dx.doi.org/10.2174/187221108786241660] [PMID: 19075912]
[69]
Ghourichay, M.P.; Kiaie, S.H.; Nokhodchi, A.; Javadzadeh, Y. Formulation and quality control of Orally Disintegrating Tablets (ODTs): Recent advances and perspectives. BioMed Res. Int., 2021, 2021(6618934)
[70]
Nagaraju, T.; Gowthami, R.; Rajashekar, M.; Sandeep, S.; Mallesham, M.; Sathish, D. Comprehensive review on oral disintegrating films. Curr. Drug Deliv., 2013, 10(1), 96-108.
[71]
Scarpa, M.; Stegemann, S.; Hsiao, W.K.; Pichler, H.; Gaisford, S.; Bresciani, M.; Paudel, A.; Orlu, M. Orodispersible films: Towards drug delivery in special populations. Int. J. Pharm., 2017, 523(1), 327-335.
[http://dx.doi.org/10.1016/j.ijpharm.2017.03.018] [PMID: 28302515]
[72]
Cornilă, A.; Iurian, S.; Tomuță, I.; Porfire, A. Orally dispersible dosage forms for paediatric use: Current knowledge and development of nanostructure-based formulations. Pharmaceutics, 2022, 14(8), 1621.
[73]
Engelen, L.; van der Bilt, A.; Schipper, M.; Bosman, F. Oral size perception of particles: Effect of size, type, viscosity and method. J. Texture Stud., 2005, 36(4), 373-386.

Rights & Permissions Print Cite
Article Metrics
11
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy